What Is the New mRNA Flu Vaccine?
The U.S. Food and Drug Administration (FDA) has approved a new mRNA-based flu vaccine for adults aged 50 and older. Unlike traditional flu vaccines that use inactivated or weakened viruses, mRNA vaccines work by instructing human cells to produce a viral protein fragment, which triggers the immune system to generate targeted antibodies.
This technology, widely used in COVID-19 vaccines, is now being applied to flu prevention, offering older adults a more robust protection option.
Why Do Older Adults Need a Stronger Flu Vaccine?
As we age, the immune system naturally weakens—a phenomenon known as "immunosenescence." Adults over 50 typically mount weaker immune responses to flu vaccines and face significantly higher risks of severe complications (such as pneumonia, hospitalization, and even death) if they contract the flu.
Research shows that traditional flu vaccines are only 40%-60% effective in older adults, while the new mRNA vaccine has demonstrated superior immunogenicity in clinical trials, inducing significantly higher antibody responses.
Key Advantages of the mRNA Flu Vaccine
- Stronger immune response: Clinical trials show that the mRNA vaccine produces significantly higher antibody levels in adults 50+ compared to traditional vaccines.
- Better cross-protection: The mRNA platform allows for faster updates to match circulating viral strains each season.
- Good safety profile: Common side effects are similar to other flu vaccines—typically injection site pain, fatigue, and headache that resolve within 1-2 days.
- Faster production: mRNA vaccines have shorter manufacturing cycles, helping respond to sudden changes in flu season.
Who Should Get It?
The vaccine is currently approved for adults aged 50 and older. The following groups are especially recommended to receive it:
- Adults over 65
- People with chronic conditions (such as heart disease, diabetes, chronic lung disease)
- Immunocompromised individuals
- Residents of long-term care facilities
If you have a history of severe allergic reactions to vaccine components or are currently experiencing an acute febrile illness, consult your doctor before vaccination.
Common Side Effects and Precautions
Like all vaccines, the mRNA flu shot may cause some mild side effects, including:
- Redness, swelling, or pain at the injection site
- Fatigue or tiredness
- Headache or muscle aches
- Low-grade fever
Severe allergic reactions are extremely rare, but you should remain at the vaccination site for 15-30 minutes after receiving the shot. If you've had a severe allergic reaction to mRNA vaccines (such as COVID-19 vaccines), be sure to inform healthcare providers in advance.
How to Get the New Flu Vaccine
The new mRNA flu vaccine is expected to be widely available during the next flu season (typically starting in autumn). You can access it through:
- Consulting your primary care physician or community clinic
- Booking an appointment at local pharmacies (such as CVS, Walgreens, etc.)
- Monitoring announcements from your local health department
It's recommended to get vaccinated before the flu season begins (usually September to October) for optimal protection.
Summary
The new mRNA flu vaccine offers adults 50 and older a more powerful option for flu protection. If you're in a high-risk group, discuss with your doctor whether this new vaccine is right for you. Maintaining healthy lifestyle habits, a balanced diet, and adequate sleep are also essential for strengthening immunity.
Want to better manage your health data? The Xiaoshu Health App can sync with Apple Health to track relevant metrics, helping you record vaccination status, temperature changes, and daily health conditions—making health management more convenient and efficient.